Valneva is Biotechnology in France that focus on Vaccine candidates business. Founded in 1999. They cover business area such as Valneva SE, life-save vaccine, its portfolio, two vaccine, traveller, Japanese encephalitis, ixiaro, cholera, diarrhoea, market vaccine, IXIARO/JESPECT, DUKORAL, Vaccine candidate, research and development program, new approvable product, future cash flow, product sale, partnering, pharmaceutical company, technology, service, invention, France.
1999
( 27 years old in 2026 )
Vaccine Candidates
-
6, Rue Alain Bombard
44800 Saint-Herblain
France
Private
Valneva SElife-save vaccineits portfoliotwo vaccinetravellerJapanese encephalitisixiarocholeradiarrhoeamarket vaccineIXIARO/JESPECTDUKORALVaccine candidateresearch and development programnew approvable productfuture cash flowproduct salepartneringpharmaceutical companytechnologyserviceinventionFrance
* We use standard office opening hours in near Valneva's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Valneva is Biotechnology business from France that founded in 1999 (27 years old in 2026), Valneva business is focusing on Vaccine Candidates.
Valneva headquarter office and corporate office address is located in 6, Rue Alain Bombard 44800 Saint-Herblain France.
Valneva was founded in France.
In 2026, Valneva is currently focus on Vaccine candidates sector.
Above is snippet of Google Trends for "Vaccine candidates" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Valneva, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
